Abraham, W. T., W. G. Fisher, et al. (2002). “Cardiac resynchronization in chronic heart failure.” N Engl J Med 346(24): 1845–1853.
Al-Khatib, S. M., A. Hellkamp, et al. (2011). “Non–evidence-based ICD implantations in the United States.” JAMA 305(1): 43–49.
Albert, N. M., G. C. Fonarow, et al. (2010). “Influence of dedicated heart failure clinics on delivery of recommended therapies in outpatient cardiology practices: Findings from the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF).” Am Heart J 159(2): 238–244.
Arnold, J. M. O., and L. J. Gula (2010). “The art and science of heart failure: Predicting the unpredict-able.” J Am Coll Cardiol 55(17): 1811–1813.
Ash, J. S., P. Z. Stavri, et al. (2003). “A consensus statement on considerations for a successful CPOE implementation.” J Am Med Inform Assoc 10(3): 229–234.
Atlas, S. J., R. A. Deyo, et al. (1996). “The Maine Lumbar Spine Study, Part III. 1-year outcomes of surgical and nonsurgical management of lumbar spinal stenosis.” Spine (Phila Pa 1976) 21(15): 1787–1794; discussion 1794–1785.
Atlas, S. J., R. B. Keller, et al. (2000). “Surgical and nonsurgical management of lumbar spinal stenosis: Four-year outcomes from the Maine Lumbar Spine Study.” Spine (Phila Pa 1976) 25(5): 556–562.
Aversano, T., L. T. Aversano, E. Passamani, et al. (2002). “Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial.” JAMA 287(15): 1943–1951.
Bangalore, S., and F. H. Messerli (2007). “Is there an ischemic threshold beyond which percutaneous coronary intervention is beneficial in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial?” Am J Cardiol 100(9): 1495.
Bates, D. W., et al. (1998). “Effect of computerized physician order entry and a team intervention on prevention of serious medical errors.” JAMA 280: 1311–1316.
Bhatt, D. L. (2007). “Interpreting the COURAGE trial: Is medical therapy as good as PCI stable angina? Two views.” Cleve Clin J Med 74(9): 618ff.
Birkmeyer, C. M., J. Lee, et al. (2002). “Will electronic order entry reduce health care costs?” Eff Clin Pract 5(2): 67–74.
Boden, W. E. (2007). “Interpreting the COURAGE trial: It takes COURAGE to alter our belief system.” Cleve Clin J Med 74(9): 623–625, 629–633.
Boden, W. E. (2008). “Management of chronic coronary disease: Is the pendulum returning to equi-poise?” Am J Cardiol 101(10A): 69D–74D.
Boden, W. E., R. A. O’Rourke, et al. (2007). “The evolving pattern of symptomatic coronary artery disease in the United States and Canada: Baseline characteristics of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial.” Am J Cardiol 99(2): 208–212.
Boden, W. E., R. A. O’Rourke, et al. (2007). “Optimal medical therapy with or without PCI for stable coronary disease.” N Engl J Med 356(15): 1503-1516.
Borden, W. B., R. F. Redberg, et al. (2011). “Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention.” JAMA 305(18): 1882–1889.